Antibiotic Susceptibilities of Bacteria Isolated within the Oral Flora of Florida Blacktip Sharks: Guidance for Empiric Antibiotic Therapy

Por Unger, Nathan R., Ritter, Erich, Borrego, Robert, Goodman, Jay, Osiyemi, Olayemi O.
Publicado em 2014

Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study

Por Osiyemi, Olayemi, Yasin, Salih, Zorrilla, Carmen, Bicer, Ceyhun, Hillewaert, Vera, Brown, Kimberley, Crauwels, Herta M.
Publicado no Infect Dis Ther (2018)

Effects of Darunavir/Ritonavir-Based Therapy on Metabolic and Anthropometric Parameters in Women and Men Over 48 Weeks

Por Currier, Judith S., Martorell, Claudia, Osiyemi, Olayemi, Yin, Michael T., Ryan, Robert, De La Rosa, Guy, Mrus, Joseph
Publicado em 2011

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

Por Eley, Timothy, Huang, Shu-Pang, Conradie, Francesca, Zorrilla, Carmen D., Josipovic, Deirdre, Botes, Mariëtte, Osiyemi, Olayemi, Hardy, Hélène, Bertz, Richard, McGrath, Donnie
Publicado em 2013

Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study

Por van Lunzen, Jan, Pozniak, Anton, Gatell, Jose M., Antinori, Andrea, Klauck, Isabelle, Serrano, Oscar, Baakili, Adyb, Osiyemi, Olayemi, Sevinsky, Heather, Girard, Pierre-Marie
Publicado no J Acquir Immune Defic Syndr (2016)

Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patients

Por Gatell, Josep M, Morales-Ramirez, Javier O, Hagins, Debbie P, Thompson, Melanie, Keikawus, Arasteh, Hoffmann, Christian, Rugina, Sorin, Osiyemi, Olayemi, Escoriu, Simona, Dretler, Robin, Harvey, Charlotte, Xu, Xia, Teppler, Hedy
Publicado no J Int AIDS Soc (2014)